The MCC Administration's expertise in organization and facilitation removes obstacles and barriers to research, allowing MCC members to focus on science and translation. Under the leadership of new Associate Director for Administration, Seanne Falconer, MBA, FACHE, Administration drives the human resources, communications, community engagement, and non-science infrastructural activities necessary to achieve the mission and vision of the MCC. MCC Administration also conducts rigorous evaluations of progress towards the goals and objectives of MCC's Strategic Plan and continues to refine and improve practices and processes to provide excellent, cost-effective services, including the development of multiple grant management software/database systems. Administration includes 120 employees who provide support for the basic, clinical, and population research and educational missions of the MCC, as well as for the 229 research members from 53 UMN departments in 13 colleges. MCC collaborates across the UMN to showcase the collaborative opportunities and research resources of the MCC when recruiting faculty, resulting in the hiring of 33 new members since 2013. The MCC FY17 budget was $19.5M, including $2.3M (13%) in support from the CCSG. Recent major achievements by MCC Administration include renovating 7000 ft2 of space to accommodate new research collaborations; creating a Shared Resource Network in a mutually beneficial partnership with the Mayo Clinic Cancer Center; establishing the Community Engagement and Education Program to engage and educate communities about cancer prevention, treatment, survivorship, and clinical research; launching the Research Development Office to provide proactive services to build strategic capacity; and supporting strategic initiatives to increase solid-tumor therapeutic clinical trials accruals by 13% in 4 years. The grants administration team managed and supported the submission of 534 proposals (429 new) since 2013, totaling over $18 million in direct costs. This research portfolio includes an NCI training grant; an ACS institutional research grant; multiple U01s; and complex, multicomponent grants, including 5 P01s, a U54, and several multiple-PI, multi-institution grants. The administration revamped the pilot grant process to ensure that funding is aligned with the Strategic Plan's priorities, and implemented a return-on-investment (ROI) analysis on all pilot awards. During the previous grant period, pilot grant investments produced an ROI of 648%, converting $3.8M in pilot funding into $24.8M in cancer-focused research grants. MCC Administration was integral in the creation of the Minnesota Cancer Clinical Trials Network, which was designed to improve cancer outcomes by providing greater access to cancer clinical trials. The State legislature appropriated the initiative $4M annually, in perpetuity, and MCC immediately established a detailed budget, hired dedicated staff, convened partner organizations, defined legal contracting aspects of a statewide network, and issued an RFA to award funds to clinics throughout the state.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA077598-22
Application #
9859349
Study Section
Subcommittee H - Clinical Groups (NCI)
Project Start
Project End
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Xu, Bin; Magli, Alessandro; Anugrah, Yoska et al. (2018) Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy. Biomaterials 183:54-66
Nikodemova, Maria; Yee, Jeremiah; Carney, Patrick R et al. (2018) Transcriptional differences between smokers and non-smokers and variance by obesity as a risk factor for human sensitivity to environmental exposures. Environ Int 113:249-258
Rashidi, Armin; Shanley, Ryan; Anasetti, Claudio et al. (2018) Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD. Bone Marrow Transplant :
Lin, Lifeng; Chu, Haitao (2018) Bayesian multivariate meta-analysis of multiple factors. Res Synth Methods 9:261-272
Mondragon-Gonzalez, Ricardo; Perlingeiro, Rita C R (2018) Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery. Dis Model Mech 11:
Kim, J-H; Frantz, A M; Sarver, A L et al. (2018) Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers. Vet Comp Oncol 16:E176-E184
Jin, Jin; Zhang, Lin; Leng, Ethan et al. (2018) Detection of prostate cancer with multiparametric MRI utilizing the anatomic structure of the prostate. Stat Med 37:3214-3229
Pierpont, Elizabeth I; Hudock, Rebekah L; Foy, Allison M et al. (2018) Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord 10:21
Carlson, Erik S; Upadhyaya, Pramod; Villalta, Peter W et al. (2018) Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-p Chem Res Toxicol 31:358-370
Lin, Lifeng; Chu, Haitao; Murad, Mohammad Hassan et al. (2018) Empirical Comparison of Publication Bias Tests in Meta-Analysis. J Gen Intern Med 33:1260-1267

Showing the most recent 10 out of 1013 publications